Company Introduction
Shenzhen Dymind Biotechnology Co., Ltd.
Located in Shenzhen, China, Dymind Biotechnology Co., Ltd. is a national-level high-tech enterprise specialized in the R&D, manufacture, sales and service of medical devices and reagents in the field of in-vitro diagnosis. Dymind is an enterprise driven by innovation, the number of R&D staff accounts for over 40%, the annual R&D expenditure exceeds 20% of revenue. Dymind has a national-level blood cells reference measurement laboratory approved by CNAS. Dymind has applied for more than 500 national-level patents since establishment and all products have been approved by the international authority quality management system. As a doctoral workstation of Guangdong Province, Dymind established a series of school-enterprise scientific research and training bases with Shenzhen University and Southern Medical University. As a innovator of joint detection of blood routine item and specific protein, Dymind launched its self-developed joint detection analyzers, including blood routine and CRP joint detection analyzers, the world's leading 5-Part and 3-Part joint detection hematology analyzers, automatic blood routine and CRP joint detection analyzers consuming less blood sample and joint detection analyzers for blood routine, CRP and SAA, which promote the new breakthrough of hematology analysis equipment, and further improve the diagnosis and treatment efficiency of medical institutions. Dymind always implements the concept of customer-focused, takes the customer demands as the highest purpose. In Dymind, the products quality is strictly controlled thorough the whole process of manufacturing, the product line is expanded rapidly. In the competition with the domestic brands, Dymind holds an increasing market share, which steady ranks second in the blood testing market. Nowadays, Dymind's products and service have been spread over 120 countries and regions around the world. Through increasingly sophisticated joint detection solutions and high quality products and services for clinical diagnosis, Dymind is always taking care of health with medical innovation.
    • 20%

      Revenue Reinvested into R&D

    • 9400+

      National Patents

    • 120+

      Countries and Regions

    • 117000+

      Squaremeter Area

  • 2018
    Excellent brand
    Launched multiple new R&D projects
    Startup the “3+3 Engineering” Service Yearly Plan
    Apply for more than 200 national patents, dozens of computer software copyrights
    Dymind was awarded as the “2018 Outstanding Brand Image Award” at the 7th China Finance and Economic Summit
    Accepted investment from Sequoia Capital China Fund and Golden Domain Linked Fund
  • 2017
    Chinese first 3-part + 5-part hematology analyzer published
    Successful launched of D7-CRP and UN73
    Introduced Yuansheng Venture Capital Shares
    Become an excellent supplier of Mei Nian Health
    Awarded as the top ten IVD brands in 2017
    Accept more than 10 million yuan government grants
    Reagent Center successfully moved into Guangming New District, headquarter covers an area of more than 10,000 square meters
  • 2016
    Won the top ten brands
    Obtained the national AAA credit company certification
    Awarded the title of “Excellent Domestic Medical Equipment” by China Medical Equipment Association
    Awarded by the medical network “The Top Ten hematology analyzer Brands Approved by the clinical inspector”
    Established technical cooperation and training bases with Shenzhen University and Southern Medical University
    The production site doubled and moved to the third floor of Nanfeng Building.
Contact us
  • Adress:7-15th Floor, Building B, High-tech park, Guangqiao Road, Tianliao Community, Yutang Street, Guangming District, Shenzhen 518107 P.R. China
  • Tel:0086-755-26008015-8123
COPYRIGHT@Shenzhen Dymind Biotechnology Co. LtdGuangdong ICP No. 17033936Powered by vancheer

Scan the QR code to follow Dymind on Wechat